Andon Health Co., Ltd. (002432.SZ)
CNY 42.22
(-0.31%)
CNY 42.22
(-0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.18 Billion | 26.31 Billion | 2.39 Billion | 2 Billion | 706.27 Million | 563.88 Million |
| Cost of Revenue | 1.23 Billion | 5.36 Billion | 875.54 Million | 877.5 Million | 502.93 Million | 394.94 Million |
| Gross Profit | 1.94 Billion | 20.94 Billion | 1.52 Billion | 1.13 Billion | 203.33 Million | 168.93 Million |
| Operating Expenses | 441.06 Million | 2.27 Billion | 559.78 Million | 659.93 Million | 352.8 Million | 282.84 Million |
| Selling, General and Administrative Expenses | 590.13 Million | 1.57 Billion | 341.95 Million | 436.05 Million | 176.73 Million | 116.99 Million |
| Research and Development Expenses | 299.52 Million | 264.88 Million | 66.73 Million | 76.54 Million | 80.03 Million | 68.86 Million |
| Other Expenses | -840.29 Million | 430.91 Million | 151.09 Million | 147.33 Million | 96.04 Million | 86.99 Million |
| Cost and Expenses | 1.61 Billion | 7.63 Billion | 1.43 Billion | 1.53 Billion | 855.74 Million | 677.78 Million |
| Operating Income | 1.61 Billion | 18.31 Billion | 1 Billion | 777.79 Million | -149.46 Million | -91.92 Million |
| Interest Expense | 15.22 Million | 4.75 Million | 13.29 Million | 6.95 Million | 8.25 Million | 6.93 Million |
| Income Tax Expense | 231.11 Million | 1.77 Billion | 65.22 Million | 2.92 Million | -8.67 Million | -2.07 Million |
| Earnings before Tax | 1.58 Billion | 18.25 Billion | 999.63 Million | 239.75 Million | 18.38 Million | -4.93 Million |
| Net Income | 1.25 Billion | 16.03 Billion | 908.64 Million | 242.32 Million | 27.05 Million | 12.68 Million |
| Earnings Per Share Basic | 2.80 | 35.14 | 2.00 | 0.56 | 0.06 | 0.03 |
| Earnings Per Share Diluted | 2.77 | 34.30 | 2.00 | 0.56 | 0.06 | 0.03 |
| Weighted Average Shares Outstanding | 447.52 Million | 456.2 Million | 454.54 Million | 432.8 Million | 432.8 Million | 422.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 452.28 Million | 467.36 Million | 454.54 Million | 432.8 Million | 432.8 Million | 422.89 Million |
| Gross Margin | 0.61 | 0.80 | 0.63 | 0.56 | 0.29 | 0.30 |
| EBIT Margin | 0.53 | 0.72 | 0.46 | 0.42 | -0.12 | 0.28 |
| Profit Margin | 0.39 | 0.61 | 0.38 | 0.12 | 0.04 | 0.02 |
| EBITDA | 1.69 Billion | 18.4 Billion | 1.11 Billion | 342.28 Million | 100.69 Million | 58.6 Million |
| Earnings Before Tax Margin | 0.51 | 0.70 | 0.42 | 0.39 | -0.21 | -0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 740.53 Million | 588.61 Million | 761.69 Million | 3.18 Billion | 483.97 Million | 462.29 Million |
| Cost of Revenue | 190.17 Million | 185.81 Million | 216.47 Million | 1.23 Billion | 285.47 Million | 134.04 Million |
| Gross Profit | 550.35 Million | 402.79 Million | 545.21 Million | 1.94 Billion | 198.49 Million | 328.25 Million |
| Operating Expenses | 302.35 Million | 239.29 Million | 251.45 Million | 1.19 Billion | 255.8 Million | 309.4 Million |
| Selling, General and Administrative Expenses | 243.68 Million | 28.34 Million | 196.26 Million | - | 177.63 Million | 340.32 Million |
| Research and Development Expenses | 58.86 Million | 65.17 Million | 53.85 Million | - | 65.21 Million | 64.3 Million |
| Other Expenses | 190.82 Thousand | 681.69 Thousand | -1.33 Million | -128.68 Million | -12.95 Million | 26.57 Million |
| Cost and Expenses | 492.53 Million | 425.11 Million | 467.93 Million | 2.43 Billion | 541.28 Million | 443.44 Million |
| Operating Income | 247.99 Million | 492.46 Million | 293.75 Million | 749.51 Million | -57.3 Million | 68.6 Million |
| Interest Expense | 16.99 Million | 19.8 Million | 11.12 Million | 12.42 Million | -1.8 Million | 11.77 Million |
| Income Tax Expense | 142.39 Million | 102.6 Million | 38.55 Million | 231.11 Million | 50.71 Million | 40.3 Million |
| Earnings before Tax | 974.94 Million | 493.14 Million | 349.03 Million | 1.58 Billion | 418.44 Million | 68.55 Million |
| Net Income | 766.88 Million | 354.33 Million | 247.42 Million | 1.25 Billion | 354.87 Million | 110.91 Million |
| Earnings Per Share Basic | 1.82 | 0.84 | 0.55 | - | 0.79 | 0.24 |
| Earnings Per Share Diluted | 1.79 | 0.81 | 0.55 | - | 0.79 | 0.23 |
| Weighted Average Shares Outstanding | 420.62 Million | 420.31 Million | 448.04 Million | 447.52 Million | 447.52 Million | 470.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 429.21 Million | 435.88 Million | 451.26 Million | 452.28 Million | 447.52 Million | 480.15 Million |
| Gross Margin | 0.74 | 0.68 | 0.72 | 0.61 | 0.41 | 0.71 |
| EBIT Margin | 1.34 | 0.59 | 0.63 | - | -0.07 | 0.32 |
| Profit Margin | 1.04 | 0.60 | 0.32 | 0.39 | 0.73 | 0.24 |
| EBITDA | 991.94 Million | 349.35 Million | 476.74 Million | - | -34.7 Million | 149.07 Million |
| Earnings Before Tax Margin | 0.33 | 0.84 | 0.39 | 0.24 | -0.12 | 0.15 |
FINKURVE
300219
600283
AMTL
CCLX
DEWM